Strategies for generating mouse model resources of human disease

References

[1] Biessels GJ, Staekenborg S, Brunner E et al. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006;5:64–74.

[2] Braak H, Braak E. Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1991;1:213–216.

[3] Bufi R, Korstanje R. The impact of genetic background on mouse models of kidney disease. Kidney Int 2022;102:38–44.

[4] Cao J, Pan J, Zhang D et al. Effects of interleukin-6 gene knockout on β-amyloid deposition and cognition in 5× FAD mouse model of Alzheimer’s disease. Acta Acad Med Sin 2022;44: 357–365.

[5] Churchill GA, Airey DC, Allayee H et al. Complex Trait Consortium. The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat Genet 2004;36:1133–1137.

[6] Gurumurthy CB, Saunders TL, Ohtsuka M. Designing and generating a mouse model: frequently asked questions. J Biomed Res 2021;35:76–90.

[7] Hirabayashi N, Hata J, Ohara T et al. Association Between Diabetes and Hippocampal Atrophy in Elderly Japanese: The Hisayama Study. Diabetes Care 2016;39:1543–1549.

[8] Hyman BT, Phelps CH, Beach TG et al. National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease. Alzheimers Dement 2012;8:1–13.

[9] Khera AV, Chaffin M, Aragam KG et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet 2018;50:1219–1224.

[10] Li W, Cao L, Li M et al. Novel spontaneous myelodysplastic syndrome mouse model. Animal Model Exp Med 2021;4:169–180.

[11] Liu Y, Xu Y, Zhang L et al. Down-regulated drebrin aggravates cognitive impairments in a mouse model of Alzheimer’s disease. Int J Mol Sci 2017;18:800.

[12] Lloyd KC. A knockout mouse resource for the biomedical research community. Ann N Y Acad Sci 2011;1245:24–26.

[13] Newman AB, Fitzpatrick AL, Lopez O et al. Dementia and Alzheimer’s disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J Am Geriatr Soc 2005;53:1101–1107.

[14] Oakley H, Cole SL, Logan S et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: potential factors in amyloid plaque formation. J Neurosci 2006;26:10129–10140.

[15] Oddo S, Caccamo A, Shepherd JD et al. Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003;39:409–421.

[16] Pennisi M, Crupi R, Di Paola R et al. Inflammasomes, hormesis, and antioxidants in neuroinflammation: Role of NRLP3 in Alzheimer disease. J Neurosci Res 2017;95:1360–1372.

[17] Pugazhenthi S, Qin L, Reddy PH. Common neurodegenerative pathways in obesity, diabetes, and Alzheimer’s disease. Biochim Biophys Acta Mol Basis Dis 2017;1863:1037–1045.

[18] Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol Med 2016;8:595–608.

[19] Sims-Robinson C, Kim B, Rosko A et al. How does diabetes accelerate Alzheimer disease pathology? Nat Rev Neurol 2010;6:551–559.

[20] Stöhr O, Schilbach K, Moll L et al. Insulin receptor signaling mediates APP processing and β-amyloid accumulation without altering survival in a transgenic mouse model of Alzheimer’s disease. Age 2013;35:83–101.

[21] Stottmann, R., Beier, D. (2014). ENU mutagenesis in the mouse. Curr Protoc Hum Genet 82:15.4.1–15.4.10.

[22] Su T, Liu H, Zhang D et al. LIM homeodomain transcription factor Isl1 affects urethral epithelium differentiation and apoptosis via Shh. Cell Death Dis 2019;10:713.

[23] Svenson KL, Gatti DM, Valdar W et al. High-resolution genetic mapping using the Mouse Diversity outbred population. Genetics 2012;190:437–447.

[24] Takeda S, Sato N, Uchio-Yamada K et al. Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes. Proc Natl Acad Sci U S A 2010;107:7036–7041.

[25] Threadgill DW, Miller DR, Churchill GA et al. The collaborative cross: a recombinant inbred mouse population for the systems genetic era. ILAR J 2011;52:24–31.

[26] Visscher PM, Yengo L, Cox NJ et al. Discovery and implications of polygenicity of common diseases. Science 2021;373:1468–1473.

[27] Weerasekera LY, Balmer LA, Ram R et al. Characterization of retinal vascular and neural damage in a novel model of diabetic retinopathy. Invest Ophthalmol Vis Sci 2015;56:3721–3730.

[28] Zhang J, Malo D, Mott R et al. Identification of new loci involved in the host susceptibility to Salmonella Typhimurium in collaborative cross mice. BMC Genomics 2018;19:303.

RIGHTS & PERMISSIONS

The Author(s) 2023. Published by Oxford University Press on behalf of Higher Education Press.